MyzStreet, I am in 100% agreement. It seems that according the the FDA's guidance, that removing, minimally manipulating the stem cells and reinjecting the stem cells is not a drug. However, removing the stem cells, shipping to anther location for processing falls under the existing rules. Is this accurate? If so, wouldn't $USRM still have full products and services for available to international clinics, and in the US continued training, partnerships with clinics and freedom to work inside those clinics? Perhaps the Stem Cell processing currently done in the USRM HQ, will be moved to clinics around the US, hopefully clinics in which $USRM has partial or full ownership.
Go $USRM
News 
Market Data 
Discover 
